LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

33.16 -2.36

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

32.7

Max

33.99

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	10.722 106.172
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	14M 73M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+35.33% upside

Turustatistika
By TradingEconomics
Turukapital	270M 2B
Eelmine avamishind	35.52
Eelmine sulgemishind	33.16

Uudiste sentiment

By Acuity

34%

66%

102 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. nov 2025, 23:36 UTC

Kuumad aktsiad

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19. nov 2025, 22:13 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19. nov 2025, 21:55 UTC

Suurimad hinnamuutused turgudel

Amgen Lung Cancer Drug Gets Full Approval From FDA

19. nov 2025, 21:43 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19. nov 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19. nov 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19. nov 2025, 23:47 UTC

Tulu

Lenovo Group 2Q EPS $2.52 >0992.HK

19. nov 2025, 23:46 UTC

Tulu

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19. nov 2025, 23:45 UTC

Tulu

Lenovo Group 2Q Rev $20.5B >0992.HK

19. nov 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19. nov 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19. nov 2025, 23:41 UTC

Tulu

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19. nov 2025, 23:41 UTC

Tulu

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19. nov 2025, 23:40 UTC

Tulu

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19. nov 2025, 22:55 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19. nov 2025, 22:41 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19. nov 2025, 22:30 UTC

Omandamised, ülevõtmised, äriostud

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19. nov 2025, 22:30 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19. nov 2025, 22:30 UTC

Omandamised, ülevõtmised, äriostud

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19. nov 2025, 22:27 UTC

Omandamised, ülevõtmised, äriostud

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19. nov 2025, 22:08 UTC

Tulu

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19. nov 2025, 22:00 UTC

Tulu

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19. nov 2025, 21:58 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19. nov 2025, 21:52 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19. nov 2025, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

19. nov 2025, 21:49 UTC

Market Talk

Tulu

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19. nov 2025, 21:38 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19. nov 2025, 21:28 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35B

19. nov 2025, 21:27 UTC

Omandamised, ülevõtmised, äriostud

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19. nov 2025, 21:24 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

35.33% tõus

12 kuu keskmine prognoos

Keskmine 46 USD 35.33%

Kõrge 62 USD

Madal 32 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

Osta

Hoia

Müü

Põhineb 10 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

102 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.